231 related articles for article (PubMed ID: 25390904)
1. Successful treatment of choroidal neovascularization complicating a choroidal osteoma with intravitreal bevacizumab.
Rao S; Gentile RC
Retin Cases Brief Rep; 2010; 4(4):303-5. PubMed ID: 25390904
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma.
Shields CL; Salazar PF; Demirci H; Benson WE; Shields JA
Retin Cases Brief Rep; 2008; 2(1):18-20. PubMed ID: 25389607
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab (avastin) for choroidal neovascularization associated with deferoxamine retinopathy.
Duval R; Olivier S
Retin Cases Brief Rep; 2011; 5(3):233-6. PubMed ID: 25390172
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
5. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
[TBL] [Abstract][Full Text] [Related]
7. Successful use of anti-VEGF treatment for subretinal hemorrhage and fluid in a young patient with choroidal osteoma.
Carle MV; Chu TG; Liao D; Boyer DS
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):169-71. PubMed ID: 24635160
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus.
Chiang A; Bianciotto C; Maguire JI; Park CH; Baker PS; Shields JA; Shields CL
Retina; 2012 Jan; 32(1):60-7. PubMed ID: 21886019
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
10. [Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT].
Mercé E; Korobelnik JF; Delyfer MN; Rougier MB
J Fr Ophtalmol; 2012 Sep; 35(7):508-13. PubMed ID: 22695057
[TBL] [Abstract][Full Text] [Related]
11. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.
Yoshikawa T; Takahashi K
Clin Ophthalmol; 2015; 9():429-37. PubMed ID: 25784788
[TBL] [Abstract][Full Text] [Related]
13. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
[TBL] [Abstract][Full Text] [Related]
14. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
15. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization.
Inoue M; Kadonosono K; Watanabe Y; Sato S; Kobayashi S; Yamane S; Ito R; Arakawa A
Retina; 2010 May; 30(5):733-8. PubMed ID: 20168271
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.
Spaide RF; Laud K; Fine HF; Klancnik JM; Meyerle CB; Yannuzzi LA; Sorenson J; Slakter J; Fisher YL; Cooney MJ
Retina; 2006 Apr; 26(4):383-90. PubMed ID: 16603955
[TBL] [Abstract][Full Text] [Related]
17. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.
Algvere PV; Steén B; Seregard S; Kvanta A
Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child.
Prasad A; Patel CC; Puklin JE
Retin Cases Brief Rep; 2009; 3(2):125-7. PubMed ID: 25391053
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
Chan WM; Lai TY; Liu DT; Lam DS
Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
